We have observed
3 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
January 19, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
VACCINE COMPOSITION WITH ALUMINIUM HYDROXIDE NANOPARTICLES
METHOD FOR FORMULATING A VACCINE CONTAINING AT LEAST TWO ANTIGENS CAPABLE OF ADSORBING ONTO ALUMINIUM OXYHYDROXIDE
METHOD FOR PRODUCING HAEMOPHILUS INFLUENZAE TYPE B ANTIGENS